Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th ed. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843..
DOI: 10.1016/j.diabres.2019.107843
Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А., Дедов И.И. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие? Терапевтический архив. 2019;91(10):4–13. doi: 10.26442/00403660.2019.10.000364..
DOI: 10.26442/00403660.2019.10.000364
Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104–112. doi: 10.14341/DM2004116-17..
DOI: 10.14341/DM2004116-17
Corriere M., Rooparinesingh N., Kalyani R.R. Epidemiology of diabetes and diabetes complications in the elderly: an emerging public health burden. Curr Diab Rep. 2013;13(6):805–813. doi: 10.1007/s11892-013-0425-5..
DOI: 10.1007/s11892-013-0425-5
Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., Byrd-Holt D.D., Li C. et al. Full accounting of diabetes and pre-diabetes in the U. S. population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287–294. doi: 10.2337/dc08-1296..
DOI: 10.2337/dc08-1296
Brown A.F., Mangione C.M., Saliba D., Sarkisian C.A. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(Suppl Guidelines):S265–S280. doi: 10.1046/j.1532-5415.51.5s.1.x..
DOI: 10.1046/j.1532-5415.51.5s.1.x
Juster-Switlyk K., Smith A.G. Updates in diabetic peripheral neuropathy. F1000Res. 2016;5:F1000FacultyRev-738. doi: 10.12688/f1000research.7898.1..
DOI: 10.12688/f1000research.7898.1
Verrotti A., Prezioso G., Scattoni R., Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne). 2014;5:205. doi: 10.3389/fendo.2014.00205..
DOI: 10.3389/fendo.2014.00205
Hicks C.W., Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep. 2019;19(10):86. doi: 10.1007/s11892-019-1212-8..
DOI: 10.1007/s11892-019-1212-8
Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017;20(1):13–41. doi: 10.14341/DM8664..
DOI: 10.14341/DM8664
Vinik A.I., Strotmeyer E.S., Nakave A.A., Patel C.V. Diabetic neuropathy in older adults. Clin Geriatr Med. 2008;24(3):407‐v. doi: 10.1016/j.cger.2008.03.011..
DOI: 10.1016/j.cger.2008.03.011
Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kempler P. et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments [published correction appears in Diabetes Care. 2010 Dec;33(12):2725]. Diabetes Care. 2010;33(10):2285–2293. doi: 10.2337/dc10-1303..
DOI: 10.2337/dc10-1303
Dimitropoulos G., Tahrani A.A., Stevens M.J. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5(1):17–39. doi: 10.4239/wjd.v5.i1.17..
DOI: 10.4239/wjd.v5.i1.17
Баринов А.Н., Новосадова М.В. Вегетативная невропатия при сахарном диабете: клинические проявления, диагностика и лечение. Неврология, нейропсихиатрия, психосоматика. 2011;3(2):25–33. doi: 10.14412/2074-2711-2011-143..
DOI: 10.14412/2074-2711-2011-143
Sabanayagam C., Liew G., Tai E.S., Shankar A., Lim S.C. Subramaniam T. et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia. 2009;52(7):1279–1289. doi: 10.1007/s00125-009-1360-5..
DOI: 10.1007/s00125-009-1360-5
Popescu S., Timar B., Baderca F., Simu M., Diaconu L., Velea I., Timar R. Age as an independent factor for the development of neuropathy in diabetic patients. Clin Interv Aging. 2016;11:313–318. doi: 10.2147/CIA.S97295..
DOI: 10.2147/CIA.S97295
Qu G.B., Wang L.L., Tang X., Wu W., Sun Y.-H. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: An update systematic review and meta-analysis. J Clin Transl Endocrinol. 2017;9:25–31. doi: 10.1016/j.jcte.2017.04.001..
DOI: 10.1016/j.jcte.2017.04.001
Rosenberger D.C., Blechschmidt V., Timmerman H., Wolff A., Treede R.-D. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm. 2020;127:589–624. doi: 10.1007/s00702-020-02145-7..
DOI: 10.1007/s00702-020-02145-7
Dyck P.J., Albers J.W., Andersen H., Arezzo J.C., Biessels G.-J., Bril V. et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27(7):620–628. doi: 10.1002/dmrr.1226..
DOI: 10.1002/dmrr.1226
Grewal A.S., Bhardwaj S., Pandita D., Lather V., Sekhon B.S. Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases. Mini Rev Med Chem. 2016;16(2):120–162. doi: 10.2174/1389557515666150909143737..
DOI: 10.2174/1389557515666150909143737
Lappas M., Permezel M., Rice G.E. Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappa B and extracellular signal-regulated kinase 1/2. J Endocrinol. 2007;193(2):269–277. doi: 10.1677/JOE-06-0081..
DOI: 10.1677/JOE-06-0081
Bachewal P., Gundu C., Yerra V.G., Kalvala A.K., Areti A., Kumar A. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy. Biofactors. 2018;44(2):109–122. doi: 10.1002/biof.1397..
DOI: 10.1002/biof.1397
Tóbon-Velasco J.C., Cuevas E., Torres-Ramos M.A. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014;13(9):1615–1626. doi: 10.2174/1871527313666140806144831..
DOI: 10.2174/1871527313666140806144831
Oates P.J. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol. 2002;50:325–392. doi: 10.1016/s0074-7742(02)50082-9..
DOI: 10.1016/s0074-7742(02)50082-9
Singleton J.R., Smith A.G., Russell J.W., Feldman E.L. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52(12):2867–2873. doi: 10.2337/diabetes.52.12.2867..
DOI: 10.2337/diabetes.52.12.2867
Boulton A.J., Malik R.A. Neuropathy of impaired glucose tolerance and its measurement. Diabetes Care. 2010;33(1):207–209. doi: 10.2337/dc09-1728..
DOI: 10.2337/dc09-1728
Papanas N., Ziegler D. Prediabetic neuropathy: does it exist? Curr Diab Rep. 2012;12(4):376–383. doi: 10.1007/s11892-012-0278-3..
DOI: 10.1007/s11892-012-0278-3
Thrainsdottir S., Malik R.A., Dahlin L.B., Wiksell P., Eriksson K.F., Rosén I. et al. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes. 2003;52(10):2615–2622. doi: 10.2337/diabetes.52.10.2615..
DOI: 10.2337/diabetes.52.10.2615
Malik R.A., Tesfaye S., Newrick P.G., Walker D., Rajbhandari S.M., Siddique I. et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia. 2005;48(3):578–585. doi: 10.1007/s00125-004-1663-5..
DOI: 10.1007/s00125-004-1663-5
Yagihashi S., Mizukami H., Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig. 2011;2(1):18–32. doi: 10.1111/j.2040-1124.2010.00070.x..
DOI: 10.1111/j.2040-1124.2010.00070.x
Lozeron P., Nahum L., Lacroix C., Ropert A., Guglielmi J.-M., Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol. 2002;249(5):569–575. doi: 10.1007/s004150200066..
DOI: 10.1007/s004150200066
Строков И.А., Фокина А.С., Ахмеджанова Л.Т., Баринов А.Н. Модернизация представлений о диабетической полиневропатии в период 2010–2018 гг. Трудный пациент. 2018;12(16):16–20. doi: 10.24411/2074-1995-2018-10038..
DOI: 10.24411/2074-1995-2018-10038
Spallone V., Morganti R., D’Amato C., Greco C., Cacciotti L., Marfia G.A. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012;29(5):578–585. doi: 10.1111/j.1464-5491.2011.03500.x..
DOI: 10.1111/j.1464-5491.2011.03500.x
Achterberg W.P., Pieper M.J., van Dalen-Kok A.H., de Waal M.W., Husebo B.S., Lautenbacher S. et al. Pain management in patients with dementia. Clin Interv Aging. 2013;8:1471–1482. doi: 10.2147/CIA.S36739..
DOI: 10.2147/CIA.S36739
Pickering G., Marcoux M., Chapiro S., David L., Rat P., Michel M. et al. An Algorithm for Neuropathic Pain Management in Older People. Drugs Aging. 2016;33(8):575–583. doi: 10.1007/s40266-016-0389-7..
DOI: 10.1007/s40266-016-0389-7
Violan C., Foguet-Boreu Q., Flores-Mateo G., Salisbury C., Blom J., Freitag M. et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7):e102149. doi: 10.1371/journal.pone.0102149..
DOI: 10.1371/journal.pone.0102149
Hein C., Forgues A., Piau A., Sommet A., Vellas B., Nourhashémi F. Impact of polypharmacy on occurrence of delirium in elderly emergency patients. J Am Med Dir Assoc. 2014;15(11):850.e11-850.e8.5E15. doi: 10.1016/j.jamda.2014.08.012..
DOI: 10.1016/j.jamda.2014.08.012
Kaku M., Vinik A., Simpson D.M. Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep. 2015;15(6):609. doi: 10.1007/s11892-015-0609-2..
DOI: 10.1007/s11892-015-0609-2
Martin C.L., Albers J., Herman W.H., Cleary P., Waberski B., Greene D.A. et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006;29(2):340–344. doi: 10.2337/diacare.29.02.06.dc05-1549..
DOI: 10.2337/diacare.29.02.06.dc05-1549
Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–117. doi: 10.1016/0168-8227(95)01064-k..
DOI: 10.1016/0168-8227(95)01064-k
Azad N., Emanuele N.V., Abraira C., Henderson W.G., Colwell J., Levin S.R. et al. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999;13(5–6):307–313. doi: 10.1016/s1056-8727(99)00062-8..
DOI: 10.1016/s1056-8727(99)00062-8
Calles-Escandón J., Lovato L.C., Simons-Morton D.G., Kendall D.M., PopBusui R., Cohen R.M. et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010;33(4):721–727. doi: 10.2337/dc09-1471..
DOI: 10.2337/dc09-1471
Chaturvedi N. Metabolic memory in the autonomic neuropathy of diabetes: implications for pathogenesis and patient care. Circulation. 2009;119(22):2865–2867. doi: 10.1161/CIRCULATIONAHA.109.867036..
DOI: 10.1161/CIRCULATIONAHA.109.867036
Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R. et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962. doi: 10.2337/diacare.28.4.956..
DOI: 10.2337/diacare.28.4.956
Lin J., Bierhaus A., Bugert P., Dietrich N., Feng Y., vom Hagen F. et al. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia. 2006;49(5):1089–1096. doi: 10.1007/s00125-006-0174-y..
DOI: 10.1007/s00125-006-0174-y
Yi X., Maeda N. alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/lowcholesterol diet. Diabetes. 2006;55(8):2238–2244. doi: 10.2337/db06-0251..
DOI: 10.2337/db06-0251
Du X., Edelstein D., Brownlee M. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia. 2008;51(10):1930–1932. doi: 10.1007/s00125-008-1100-2..
DOI: 10.1007/s00125-008-1100-2
Храмилин В.Н., Демидова И.Ю., Игнатова О.Ю. Оценка эффективности различных режимов пероральной терапии альфа-липоевой кислотой болевой формы диабетической периферической полинейропатии. Сахарный диабет. 2010;(2):28–32. doi: 10.14341/2072-0351-5670..
DOI: 10.14341/2072-0351-5670
Mijnhout G.S., Kollen B.J., Alkhalaf A., Kleefstra N., Bilo H.J.G. Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. Int J Endocrinol. 2012;2012:456279. doi: 10.1155/2012/456279..
DOI: 10.1155/2012/456279
Lee W.Y., Orestes P., Latham J., Naik A.K., Nelson M.T., Vitko I. et al. Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway. J Neurosci. 2009;29(30):9500–9509. doi: 10.1523/JNEUROSCI.5803-08.2009..
DOI: 10.1523/JNEUROSCI.5803-08.2009
Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997;20(3):369–373. doi: 10.2337/diacare.20.3.369..
DOI: 10.2337/diacare.20.3.369
Serhiyenko V., Serhiyenko L., Serhiyenko A. Alpha-lipoic acid and diabetic cardiac autonomic neuropathy. MOJ Public Health. 2019;8(1):8‒10. Available at: https://medcraveonline.com/MOJPH/MOJPH-08-00276.pdf.https://medcraveonline.com/MOJPH/MOJPH-08-00276.pdf
Serhiyenko V., Serhiyenko L., Serhiyenko A. Alpha-lipoic acid and diabetic cardiac autonomic neuropathy. MOJ Public Health. 2019;8(1):8‒10. Available at: https://medcraveonline.com/MOJPH/MOJPH-08-00276.pdf.https://medcraveonline.com/MOJPH/MOJPH-08-00276.pdf
Ziegler D., Low P.A., Litchy W.J., Boulton A.J.M, Vinik A.I., Freeman R. et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34(9):2054–2060. doi: 10.2337/dc11-0503..
DOI: 10.2337/dc11-0503
Attal N., Cruccu G., Baron R., Haanpää M., Hansson P., Jensen T.S., Nurmikko T. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88. doi: 10.1111/j.1468-1331.2010.02999.x..
DOI: 10.1111/j.1468-1331.2010.02999.x
Bril V., England J.D., Franklin G.M., Backonja M., Cohen J.A., Del Toro D.R. et al. Evidence-based guideline: treatment of painful diabetic neuropathy– report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. Muscle Nerve. 2011;43(6):910–917. doi: 10.1002/mus.22092..
DOI: 10.1002/mus.22092
Çakici N., Fakkel T.M., van Neck J.W., Verhagen A.P., Coert J.H. Systematic review of treatments for diabetic peripheral neuropathy. Diabet Med. 2016;33(11):1466–1476. doi: 10.1111/dme.13083..
DOI: 10.1111/dme.13083
Gibson W., Wand B.M., O’Connell N.E. Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults. Cochrane Database Syst Rev. 2017;9(9):CD011976. doi: 10.1002/14651858.CD011976.pub2..
DOI: 10.1002/14651858.CD011976.pub2